HOME › DRUGS › PEMBROLIZUMAB
ACTIVE SUBSTANCE / INN

PEMBROLIZUMAB

Brand name(s): Keytruda, KEYTRUDA, KEYTRUDA QLEX
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761467
Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, No…
ACTIVE SUBSTANCE
Pembrolizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Merck Sharp & Dohme B.V., MERCK SHARP DOHME
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KEYTRUDA QLEXBLA761467MERCK SHARP DOHMEPrescription
KEYTRUDABLA125514MERCK SHARP DOHMEPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KeytrudaMerck Sharp & Dohme B.V.Authorised17/07/2015Melanoma;Hodgkin Disease;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Ca…

FULL INTELLIGENCE ON PEMBROLIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →